Jessica Rose
November 19, 2022
Unacceptable Jessica (Substack)

This Substack post by scientist Dr Jessica Rose presents obstetric data on new patient numbers and miscarriages for 2020–2022 and includes multiple comparative charts. Dr Rose examines changes in miscarriage counts and rates and discusses their timing in relation to the rollout of COVID-19 injectable products.

I have been contacted by an obstetrician/gynecologist with some data they had been collecting for the past 2 years as part of their sacred duty in their practice. This person collected new patient data and miscarriage data and also has average rates for the past years...

Bar chart comparing new patient numbers (blue) and miscarriage numbers (orange) for 2020, 2021 and 2022. New patient totals decrease over the three years while miscarriage totals increase.

[F]or each month in both 2021 and 2022, the number of new patients each month falls below the 2020 average of between 32 and 40...

The numbers of miscarriages are higher for each month except for November 2021... when we plot the rates, it becomes abundantly clear that the miscarriage rates are twice that in 2022 than they were for 2021... on average...

Monthly miscarriage rates for 2021 (blue) and 2022 (red), with average loss rates of 8% and 15% respectively

If we only look at the December 2021 miscarriage rate and compare it to the 2022 rates, we get a clearer picture of what the miscarriage rates have been since the COVID-19 injectable products have been rolled out in the U.S...

So with just a few points of data, we get an unbiased assessment of the change in miscarriage rates in 2021 and 2022. It is pretty clear from this data that, for some reason, there are more miscarriages and fewer new moms to begin with in 2022...

I don’t think it’s lockdowns. I think it’s the injections.”

Monthly miscarriage rates from December 2021 through November 2022, with an orange line marking the 7% average for December 2021–November 2021

Dr Jessica Rose holds a BSc in Applied Mathematics and an MSc in Immunology from Memorial University of Newfoundland. She earned a PhD in Computational Biology from Bar Ilan University in Israel and completed postdoctoral fellowships in Molecular Biology and Biochemistry at the Technion – Israel Institute of Technology. Her research experience includes immunology, microbiology, systems biology, and data analysis, with publications in peer-reviewed journals.

document
adverse events,COVID-19,reproductive system issues,vaccines